|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2004-04-19 Purchase |
2004-04-21 2:05 pm | NEUROGEN CORP | NRGN | TISCH THOMAS J (10% owner) | 267,858 | $7 | $1,875,006 | 1,247,108 (Indirect) | View |
| 2004-04-19 Purchase | 2004-04-21 2:04 pm |
NEUROGEN CORP | NRGN | TISCH JAMES S (10% owner) | 267,858 | $7 | $1,875,006 | 947,108 (Indirect) |
View |
| 2004-04-19 Purchase | 2004-04-21 2:04 pm | NEUROGEN CORP | NRGN | TISCH DANIEL R (10% owner) | 267,858 | $7 | $1,875,006 | 947,108 (Indirect) | View |
| 2004-04-19 Purchase |
2004-04-21 2:03 pm |
NEUROGEN CORP | NRGN | TISCH ANDREW H (10% owner) | 267,858 | $7 | $1,875,006 | 947,108 (Indirect) | View |
| 2003-08-05 Purchase | 2003-08-07 5:31 pm |
NEUROGEN CORP | NRGN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 46,000 | $4.823 | $221,841 | 2,393,663 (Indirect) |
View |
| Transaction & Date |
Reported Date | Company | Symbol | Insider Relationship | Shares Traded |
Average Price | Total Amount |
Shares Ownership | Filing |
| 2008-07-25 Purchase | 2008-11-13 4:38 pm | NEUROGEN CORP | NRGN | Baker Biotech Capital (GP), LLC BAKER JULIAN BAKER FELIX (Director 10% owner) | 1,304,550 | $0 | $0 | 3,500,059 (Indirect) | View |
| 2008-07-25 Purchase | 2008-11-13 4:36 pm | NEUROGEN CORP | NRGN | Baker Brothers Life Sciences Capital (GP), LLC BAKER JULIAN BAKER FELIX (Director 10% owner) | 1,371,162 | $0 | $0 | 3,678,823 (Indirect) |
View |
| 2008-07-25 Purchase | 2008-11-13 4:30 pm |
NEUROGEN CORP | NRGN | Baker / Tisch Capital (GP), LLC BAKER JULIAN BAKER FELIX (Director 10% owner) | 125,112 | $0 | $0 | 335,668 (Indirect) |
View |
| 2008-07-25 Purchase |
2008-11-13 4:28 pm | NEUROGEN CORP | NRGN | Baker Bros. Capital (GP), LLC BAKER JULIAN BAKER FELIX (Director 10% owner) | 257,504 | $0 | $0 | 690,856 (Indirect) |
View |
| 2008-07-25 Purchase | 2008-07-28 4:31 pm |
NEUROGEN CORP | NRGN | LEFF JONATHAN S (Director) | 4,999,982 | $0 | $0 | 13,571,411 (Indirect) | View |
| 2008-07-25 Purchase |
2008-07-28 4:30 pm | NEUROGEN CORP | NRGN | WARBURG PINCUS PRIVATE EQUITY VIII L P Warburg Pincus Partners LLC WARBURG PINCUS LLC WARBURG PINCUS & CO KAYE CHARLES R LANDY JOSEPH (Director 10% owner) | 4,999,982 | $0 | $0 | 13,571,411 (Direct) | View |
| 2006-04-25 Other | 2006-04-28 3:15 pm |
NEUROGEN CORP | NRGN | Baker Brothers Life Sciences Capital (GP), LLC Baker Biotech Capital II (GP), LLC Baker Biotech Capital II (Z) (GP), LLC BAKER JULIAN BAKER FELIX (Director 10% owner) | 4,615,322 | $0 | $0 | 2,307,661 (Indirect) | View |
| 2004-10-13 Other | 2004-11-02 9:22 pm | NEUROGEN CORP | NRGN | BAKER BIOTECH CAPITAL II GP LLC BAKER JULIAN BAKER FELIX (Director 10% owner) | 268,465 | $0 | $0 | 2,039,196 (Indirect) | View |
| Transaction & Date |
Reported Date |
Exercisable Expiration |
Company | Symbol | Insider Relationship | Shares Traded |
Conversion Price |
Shares Ownership | Filing |
| 2009-09-15 Option Award | 2009-09-16 4:20 pm | N/A 2019-09-15 |
NEUROGEN CORP | NRGN | LAMATTINA JOHN L (Director) | 2,500 | $0.236 | 2,500 (Direct) | View |
| 2009-09-15 Option Award | 2009-09-16 4:19 pm | N/A 2019-09-15 |
NEUROGEN CORP | NRGN | HEN STEWART (Director) | 2,500 | $0.236 | 2,500 (Direct) | View |
| 2009-09-15 Option Award | 2009-09-16 4:19 pm |
N/A 2019-09-15 | NEUROGEN CORP | NRGN | BAKER JULIAN (Director) | 2,500 | $0.236 | 2,500 (Direct) | View |
| 2009-09-15 Option Award |
2009-09-16 4:18 pm | N/A 2019-09-15 | NEUROGEN CORP | NRGN | BROSHY ERAN (Director) | 2,500 | $0.236 | 2,500 (Direct) | View |
| 2009-09-15 Option Award | 2009-09-16 4:17 pm | N/A 2019-09-15 |
NEUROGEN CORP | NRGN | SAXTON CRAIG (Director) | 2,500 | $0.236 | 2,500 (Direct) |
View |
| 2009-09-15 Option Award |
2009-09-16 10:44 am |
N/A 2019-09-15 |
NEUROGEN CORP | NRGN | SIMON JOHN (Director) | 2,500 | $0.236 | 2,500 (Direct) | View |
| 2009-06-15 Option Award | 2009-06-16 12:24 pm |
N/A 2019-06-15 | NEUROGEN CORP | NRGN | SAXTON CRAIG (Director) | 2,500 | $0.28 | 2,500 (Direct) | View |
| 2008-07-25 Purchase | 2008-11-13 4:38 pm | N/A N/A | NEUROGEN CORP | NRGN | Baker Biotech Capital (GP), LLC BAKER JULIAN BAKER FELIX (Director 10% owner) | 50,175 | $0 | 0 (Indirect) |
View |
| 2008-07-25 Purchase |
2008-11-13 4:36 pm | N/A N/A | NEUROGEN CORP | NRGN | Baker Brothers Life Sciences Capital (GP), LLC BAKER JULIAN BAKER FELIX (Director 10% owner) | 52,737 | $0 | 0 (Indirect) |
View |
| 2008-07-25 Purchase | 2008-11-13 4:30 pm |
N/A N/A | NEUROGEN CORP | NRGN | Baker / Tisch Capital (GP), LLC BAKER JULIAN BAKER FELIX (Director 10% owner) | 4,812 | $0 | 0 (Indirect) | View |
| 2008-07-25 Purchase |
2008-11-13 4:28 pm | N/A N/A |
NEUROGEN CORP | NRGN | Baker Bros. Capital (GP), LLC BAKER JULIAN BAKER FELIX (Director 10% owner) | 9,904 | $0 | 0 (Indirect) | View |
| 2008-07-25 Option Award | 2008-07-29 3:05 pm |
2008-07-24 N/A | NEUROGEN CORP | NRGN | Stankovic Srdjan R. (Exec VP and CDO) | 96,000 | $1.2 | 96,000 (Direct) |
View |
| 2008-07-25 Option Award |
2008-07-29 3:04 pm | 2008-07-24 N/A |
NEUROGEN CORP | NRGN | DAVIS STEPHEN (President, CEO Director) | 224,000 | $1.2 | 224,000 (Direct) |
View |
| 2008-07-25 Option Award | 2008-07-29 3:03 pm | 2008-07-24 N/A | NEUROGEN CORP | NRGN | Pitler Thomas A. (SVP, CBO and CFO) | 80,000 | $1.2 | 80,000 (Direct) | View |
| 2008-07-25 Purchase | 2008-07-28 4:31 pm | N/A N/A | NEUROGEN CORP | NRGN | LEFF JONATHAN S (Director) | 192,307 | $0 | 0 (Indirect) | View |
| 2008-07-25 Purchase | 2008-07-28 4:30 pm |
N/A N/A | NEUROGEN CORP | NRGN | WARBURG PINCUS PRIVATE EQUITY VIII L P Warburg Pincus Partners LLC WARBURG PINCUS LLC WARBURG PINCUS & CO KAYE CHARLES R LANDY JOSEPH (Director 10% owner) | 192,307 | $0 | 0 (Direct) | View |
| 2008-06-15 Option Award |
2008-06-17 2:30 pm |
N/A 2018-06-15 | NEUROGEN CORP | NRGN | BAKER FELIX (Director) | 2,500 | $0.91 | 2,500 (Direct) | View |
| 2007-12-20 Option Award |
2007-12-21 5:06 pm |
2008-12-20 N/A |
NEUROGEN CORP | NRGN | KRAUSE JAMES (Senior VP Biology) | 15,750 | $3.56 | 15,750 (Direct) |
View |
| 2007-12-20 Option Award | 2007-12-21 5:05 pm | 2008-12-20 N/A | NEUROGEN CORP | NRGN | Chenard Bertrand L (SR VP, Chemistry) | 15,750 | $3.56 | 15,750 (Direct) |
View |
| 2007-12-20 Option Award | 2007-12-21 5:05 pm | 2008-12-20 N/A | NEUROGEN CORP | NRGN | HUTCHISON ALAN (Exec VP Discovery Research) | 18,375 | $3.56 | 18,375 (Direct) |
View |
| 2007-12-20 Option Award | 2007-12-21 5:03 pm | 2008-12-20 N/A | NEUROGEN CORP | NRGN | KOSTER WILLIAM H (Chief Executive Officer Director) | 31,500 | $3.56 | 31,500 (Direct) | View |
| 2007-01-17 Option Award |
2007-01-19 08:25 am |
2010-01-17 2015-01-17 | NEUROGEN CORP | NRGN | Uden Stephen (Exec VP, Research & Developmen) | 90,000 | $6.2 | 90,000 (Direct) | View |
| 2007-01-17 Option Award |
2007-01-19 08:21 am | 2010-01-17 2015-01-17 | NEUROGEN CORP | NRGN | Dill Jeffrey (VP and General Counsel) | 40,000 | $6.2 | 40,000 (Direct) | View |
| 2006-12-15 Option Award |
2006-12-19 5:15 pm | 2007-12-15 N/A | NEUROGEN CORP | NRGN | Ochoa Ricardo (VP, Pre-Clinical Safety) | 5,688 | $5.78 | 5,688 (Direct) | View |
| 2006-03-15 Option Award |
2006-03-16 3:22 pm |
N/A 2016-03-15 |
NEUROGEN CORP | NRGN | WOOLSEY SUZANNE (Director) | 2,500 | $6.56 | 2,500 (Indirect) |
View |
| 2006-03-15 Option Award | 2006-03-16 3:20 pm |
N/A 2016-03-15 |
NEUROGEN CORP | NRGN | NOVITCH MARK M D (Director) | 2,500 | $6.56 | 2,500 (Direct) |
View |
| 2006-03-15 Option Award |
2006-03-16 3:17 pm |
N/A 2016-03-15 | NEUROGEN CORP | NRGN | BUTLER ROBERT N (Director) | 2,500 | $6.56 | 2,500 (Direct) | View |
| 2005-12-16 Option Award |
2005-12-20 5:12 pm |
2006-12-16 N/A |
NEUROGEN CORP | NRGN | Ritrovato Charles (SR VP Drug Regulatory Affairs) | 23,760 | $7.88 | 23,760 (Direct) | View |
| 2005-03-15 Option Award | 2005-03-16 2:31 pm | N/A 2015-03-15 | NEUROGEN CORP | NRGN | CARLUCCI FRANK C (Director) | 2,500 | $7.36 | 2,500 (Direct) | View |
| 2004-12-21 Option Award |
2004-12-23 4:32 pm |
2005-12-21 N/A |
NEUROGEN CORP | NRGN | LEE LAI FOON (Vice President Finance) | 20,000 | $9.05 | 20,000 (Direct) |
View |
| 2003-05-19 Option Award | 2004-04-28 2:41 pm | N/A 2013-05-19 | NEUROGEN CORP | NRGN | BLOOM BARRY (Director) | 4,000 | $4.25 | 4,000 (Direct) | View |
| 2003-12-15 Option Award | 2003-12-18 5:03 pm | 2004-12-15 N/A | NEUROGEN CORP | NRGN | SHAW KENNETH (SVP Chemistry & Pharm R&D) | 27,000 | $8.79 | 27,000 (Direct) |
View |
| 2003-12-15 Option Award | 2003-12-18 5:01 pm |
2004-12-15 N/A | NEUROGEN CORP | NRGN | CASELLA JAMES (Sr. VP Clinical Development) | 27,000 | $8.79 | 27,000 (Direct) |
View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Fri, 20 Nov 2009 23:16:47 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |